In this way, we can get information about how people come to us
As GLP-1 treatments become more mainstream and accessible, gyms, fast food companies and other fitness and wellness brands are offering programs and products to support those using weight loss drugs
But what does the data actually show
Liraglutide has shown promising results in clinical trials for treating other conditions, including nonalcoholic fatty liver disease, polycystic ovary syndrome, and neurodegenerative diseases
A higher-dose semaglutide tablet (25 mg) led to an average weight loss of about 1417% over a little more than a year , along with additional benefits like lower blood pressure and reduced inflammation
As a result, the critical question of whether any observed pregnancy benefit is independent of metabolic change remains unresolved